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group (p<0.01). Bcl-2 expression in the study group was significantly decreased 
compared with the control group (p<0.01). p53 showed no significant differences 
between the two groups (p=0.791). There were statistically significant differences 
in fistula failure between the study group and control group (26.7% versus 6.7%, 
p=0.038). The association we have found between previously punctured veins and 
apoptosis indicates the role that venipuncture may play in the development of apop-
tosis. Patients with increased apoptosis showed an increased fistula failure, which is 
of importance for the improvement of the AVF procedure itself.
Keywords: native vein wall; arteriovenous fistula; hemodialysis; apoptosis; fis-
tula failure.
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Survivin, encoded by BIRC5 gene, belongs to the family of inhibitors of apopto-
sis (IAP) proteins. Survivin is an essential chromosomal passenger protein required 
for mitotic progression. It is also an inhibitor of apoptosis and can prevent caspase-
mediated cell death. It is usually expressed in embryonic tissues and homozygous 
survivin deletion results in early embryonic death, showing its essential role in cell 
development, differentiation and homeostasis. In healthy organisms it is not ex-
pressed in differentiated tissues, while its expression is markedly increased in most 
cancers (including bladder cancer, lung cancer, breast cancer, stomach, esophagus, 
liver, ovarian cancers and hematological cancers).
In tumors its presence correlates with increased resistance to chemo- and radio-
therapy, as well as worse survival rate. Although its expression is usually confined to 
G2-phase and mitosis, survivin is in cancer often expressed throughout the cell cycle. 
At least 5 different splice variants of the survivin gene have been reported in hu-
mans so far (wild type, 2α, 2B, 3B and deltaEx3). All survivin protein isoforms arising 
from the splice variants share the same N-terminus region, but differ in the carboxyl 
end. The transcript expression levels of various survivin isoforms have been signifi-
cantly associated with clinico-pathologic characteristics in several cancers.
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Several BIRC5 polymorphisms in promoter and 3’UTR regions were studied in 
various types of cancer, and were found to be correlated with susceptibility (gastric, 
bladder and hepatocellular), survival (colorectal and breast) or age of onset (ovarian 
cancer).
In this study we investigated the role of BIRC5 polymorphisms and survivin 
gene expression in several types of cancer. 74 normal samples, 48 oral and oro-
pharyngeal squamous cell carcinoma (SCC) samples, 35 breast cancer (BC) sam-
ples and 40 ovarian carcinoma (OC) samples were typed for BIRC5 polymorphisms 
using high resolution melting analysis and Sanger sequencing. For samples with 
available tumor tissues, either fresh frozen (48 SCC samples and 23 OC samples) or 
paraffin embedded (26 BC samples), survivin expression was measured with qPCR 
or immunohistochemistry. For OC samples, levels of different survivin isoforms 
were also determined.
19 polymorphisms were found, 7 were found in promoter region, 1 in 5’UTR, 4 
in coding region and 7 in 3’UTR. 10 polymorphisms were found in all 4 groups, 5 in 
3 groups, 1 in 2 groups and 3 in only 1 group of samples. Two of the polymorphisms 
that were found only in one sample each have not previously been reported. Both, 
one in exon 2B (c.221+1199G>A), and second, in 3’UTR (c.9349G>C) were found in 
SCC samples.
47 SCC samples showed survivin mRNA expression. 24 BC samples showed 
protein survivin expression. All 23 OC samples expressed wild type survivin, but 
isoform expression varied greatly. The highest expression of all splice variants was 
of survivin 2α, then wild type survivin, followed by survivin deltaEx3 and sur-
vivin 3B. The lowest expression was of the splice variant survivin 2B, which was 
expressed in only 16 of 23 samples analyzed. All splice variants had higher expres-
sion in ovarian cancer compared to healthy Fallopian tube tissue.
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